Parental Acceptance of a Mandatory Human Papillomavirus (HPV) Vaccination Program
Parental Acceptance of a Mandatory Human Papillomavirus (HPV) Vaccination Program
复制标题
DOI：
10.3122/jabfm.2010.02.090091
复制
发表时间：
2010-03-01
影响因子：
2.9
通讯作者：
Waller, Jennifer L.
中科院分区：
文献类型：
--
作者：
Ferris, Daron;Horn, Leslie;Waller, Jennifer L.
目的：本研究的目的是确定影响家长接受强制性学校为基础的人乳头瘤病毒（HPV）疫苗接种programmes.Methods的因素：325名家长，9至17岁的儿童，完成了一个方便的样本53项调查。调查问题针对他们对HPV，HPV疫苗和强制性HPV疫苗接种计划的看法。采用卡方检验（chi（2）test）检验调查项目之间的关系。认为应该强制接种HPV疫苗的父母的特征包括有限的财政资源（P = .03），HPV相关疾病史（P = 0.04），了解孩子的易感性（P = .03），对孩子接种HPV疫苗的兴趣（P = .0001），以及疫苗降低宫颈癌风险的知识（P = .001）。12至14岁儿童的父母（P = .02）或谁知道疫苗降低了他们的孩子患生殖器疣（P = .02）和宫颈癌（P = .001）的风险将更有可能遵守强制性HPV疫苗program.Conclusions：某些特征定义的父母谁支持强制性HPV疫苗接种计划。对父母和卫生保健提供者进行更多的教育应提高疫苗接种率，最终降低HPV相关疾病的发病率和死亡率。（J Am Board Fam Med 2010;23：220-229.）
Objectives: The objective of this study was to determine factors that influence parent's acceptance of a mandatory school-based human papillomavirus (HPV) vaccination program.Methods: A convenience sample of 325 parents, with children aged 9 to 17 years old, completed a 53-item survey. Survey questions targeted their opinions about HPV, the HPV vaccine, and a mandatory HPV vaccination program. chi(2) tests were used to examine relationships between survey items.Results: Characteristics of parents who believed the HPV vaccine should be mandated included limited financial resources (P = .03), history of HPV-related disease (P = .04), understanding their child's susceptibility (P = .03), interest in HPV vaccination for their child (P = .0001), and knowledge that the vaccine reduces the risk of cervical cancer (P = .001). Parents of children aged 12 to 14 years old (P = .02) or who knew the vaccine reduced their child's risk of developing genital warts (P = .02) and cervical cancer (P = .001) would be more likely to comply with a mandatory HPV vaccine program.Conclusions: Certain characteristics define parents who support a mandatory HPV vaccination program. Greater education of parents and health care providers should improve vaccination uptake, which ultimately reduces morbidity and mortality from HPV related diseases. (J Am Board Fam Med 2010;23:220-229.)